Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 3
1978 2
1980 4
1982 5
1983 1
1984 4
1986 3
1987 3
1989 2
1990 2
1991 2
1992 7
1993 11
1994 6
1995 6
1996 4
1997 14
1998 13
1999 14
2000 7
2001 12
2002 15
2003 15
2004 19
2005 14
2006 32
2007 25
2008 28
2009 33
2010 55
2011 51
2012 63
2013 49
2014 16
2015 24
2016 13
2017 3
2018 7
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

552 results

Results by year

Filters applied: . Clear all
Page 1
Pancreatic cancer: understanding and overcoming chemoresistance.
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Sarkar FH. Wang Z, et al. Among authors: sarkar fh. Nat Rev Gastroenterol Hepatol. 2011 Jan;8(1):27-33. doi: 10.1038/nrgastro.2010.188. Epub 2010 Nov 23. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21102532 Review.
MDM2 inhibitors for pancreatic cancer therapy.
Azmi AS, Philip PA, Almhanna K, Beck FW, Sarkar FH, Mohammad RM. Azmi AS, et al. Among authors: sarkar fh. Mini Rev Med Chem. 2010 Jun;10(6):518-26. doi: 10.2174/138955710791384054. Mini Rev Med Chem. 2010. PMID: 20377522 Review.
Perspectives on medicinal properties of mangiferin.
Vyas A, Syeda K, Ahmad A, Padhye S, Sarkar FH. Vyas A, et al. Among authors: sarkar fh. Mini Rev Med Chem. 2012 May;12(5):412-25. doi: 10.2174/138955712800493870. Mini Rev Med Chem. 2012. PMID: 22303941 Review.
Current trends in the chemoprevention of cancer.
Sarkar FH. Sarkar FH. Pharm Res. 2010 Jun;27(6):945-9. doi: 10.1007/s11095-010-0146-2. Epub 2010 Apr 17. Pharm Res. 2010. PMID: 20401521 No abstract available.
Clinical implication of microRNAs in molecular pathology.
Sethi S, Ali S, Kong D, Philip PA, Sarkar FH. Sethi S, et al. Among authors: sarkar fh. Clin Lab Med. 2013 Dec;33(4):773-86. doi: 10.1016/j.cll.2013.08.001. Epub 2013 Oct 9. Clin Lab Med. 2013. PMID: 24267185 Review.
Pancreatic cancer: pathogenesis, prevention and treatment.
Sarkar FH, Banerjee S, Li Y. Sarkar FH, et al. Toxicol Appl Pharmacol. 2007 Nov 1;224(3):326-36. doi: 10.1016/j.taap.2006.11.007. Epub 2006 Nov 11. Toxicol Appl Pharmacol. 2007. PMID: 17174370 Free PMC article. Review.
A molecular rheostat at the interface of cancer and diabetes.
Osman MA, Sarkar FH, Rodriguez-Boulan E. Osman MA, et al. Among authors: sarkar fh. Biochim Biophys Acta. 2013 Aug;1836(1):166-76. doi: 10.1016/j.bbcan.2013.04.005. Epub 2013 Apr 29. Biochim Biophys Acta. 2013. PMID: 23639840 Free PMC article. Review.
Indole-3-carbinol and prostate cancer.
Sarkar FH, Li Y. Sarkar FH, et al. J Nutr. 2004 Dec;134(12 Suppl):3493S-3498S. doi: 10.1093/jn/134.12.3493S. J Nutr. 2004. PMID: 15570059 Free article. Review.
MicroRNAs in personalized cancer therapy.
Sethi S, Ali S, Sethi S, Sarkar FH. Sethi S, et al. Among authors: sarkar fh. Clin Genet. 2014 Jul;86(1):68-73. doi: 10.1111/cge.12362. Epub 2014 Mar 20. Clin Genet. 2014. PMID: 24635652 Review.
552 results